| Literature DB >> 34884799 |
Malik Aydin1,2, Jana Dietrich3, Joana Witt4, Maximiliane S C Finkbeiner5, Jonas J-H Park6, Stefan Wirth2, Christine E Engeland5, Friedrich Paulsen3,7, Anja Ehrhardt5.
Abstract
There is a lack of knowledge regarding the connection between the ocular and nasal epithelia. This narrative review focuses on conjunctival, corneal, ultrastructural corneal stroma, and nasal epithelia as well as an introduction into their interconnections. We describe in detail the morphology and physiology of the ocular surface, the nasolacrimal ducts, and the nasal cavity. This knowledge provides a basis for functional studies and the development of relevant cell culture models that can be used to investigate the pathogenesis of diseases related to these complex structures. Moreover, we also provide a state-of-the-art overview regarding the development of 3D culture models, which allow for addressing research questions in models resembling the in vivo situation. In particular, we give an overview of the current developments of corneal 3D and organoid models, as well as 3D cell culture models of epithelia with goblet cells (conjunctiva and nasal cavity). The benefits and shortcomings of these cell culture models are discussed. As examples for pathogens related to ocular and nasal epithelia, we discuss infections caused by adenovirus and measles virus. In addition to pathogens, also external triggers such as allergens can cause rhinoconjunctivitis. These diseases exemplify the interconnections between the ocular surface and nasal epithelia in a molecular and clinical context. With a final translational section on optical coherence tomography (OCT), we provide an overview about the applicability of this technique in basic research and clinical ophthalmology. The techniques presented herein will be instrumental in further elucidating the functional interrelations and crosstalk between ocular and nasal epithelia.Entities:
Keywords: 3D cell culture; goblet cells; infection; nasal epithelium; ocular surface epithelium
Mesh:
Year: 2021 PMID: 34884799 PMCID: PMC8657734 DOI: 10.3390/ijms222312994
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Morphology and physiology of the ocular surface epithelium, nasolacrimal duct, and nasal epithelium. (A) Schematic drawing of the anatomical connection between the ocular surface and the nasal cavity via the nasolacrimal duct. Illustration by Jörg Pekarsky, Institute of Functional and Clinical Anatomy, FAU Erlangen-Nürnberg, (B) Hematoxylin and Eosin staining (HE) of the human cornea, (C) the human bulbar conjunctiva, (D) the human nasolacrimal duct, and (E) the human nasal cavity. E: epithelium, S: stroma; arrowheads mark goblet cells, C: cinocilia marked by arrows; Magnification is 200× with 100 µm scale bar.
Figure 2Summary of different corneal cell culture models with their benefits and shortcomings. This figure was adapted from [83], and was created with BioRender.com.
Figure 3Development of 3D conjunctival epithelial cell culture model. (A) Hematoxylin and Eosin staining (HE) of human bulbar conjunctiva. (B) 3D cultured human conjunctival epithelial cells growing on a transwell insert. Isolation as explant culture on transwell with cultivation (21 days) and differentiation performed according to reference [89]. E = epithelium, Su = superficial epithelial cells, I = intermediate cells, B = basal cells, S = Stroma, T = transwell; Magnification is 200× (A) and 400× (B) with 50 µm scale bar.
3D cell culture conditions of conjunctival epithelium.
| # | Tissue Source | Goblet Cells | Cell Culture Conditions | Ref. |
|---|---|---|---|---|
| 1 | Rabbit-derived conjunctiva | yes |
New Zealand white rabbit-derived palpebral and bulbar conjunctiva Isolation of conjunctival progenitor cells by homogenization of cells using collagenase and Trypsin-EDTA Expansion of conjunctival cells at 1 × 107 cells/mL in bioprinted micro-constructs in conjunctival stem cells (CjSC)-medium Goblet cell differentiation was initiated by a special goblet cell differentiation medium for seven days No efforts were made to analyze the presence of mature conjunctival epithelium Goblet cells were detected by positive MUC5AC | [ |
| 2 | Human-derived conjunctiva |
Human donor-derived bulbar conjunctiva after cryopreservation for up to six months | [ | |
| no |
Isolation and expansion of conjunctival progenitor cells on feeder cells in conjunctival epithelial cells (CEC) medium by explant culture Expansion and differentiation by seeding 4.4 × 105 cell/cm2 onto a decellularized porcine conjunctiva in a cell crown, submerged cultivation in CEC medium for 7 days followed by cultivation at air-liquid interface in differentiation medium Mature conjunctival cells were detected by stratification, morphology, and positive cytokeratin 19 staining No goblet cells were detected by MUC5AC staining | |||
| few |
Isolation on decellularized porcine conjunctiva Isolation and expansion of conjunctival cells by direct outgrowth from an explant piece onto a scaffold Expansion on decellularized porcine conjunctiva placed in a cell crown, submerged cultivation in CEC medium for 7 days followed by cultivation at air-liquid interface in differentiation medium Mature conjunctival cells were detected by stratification, morphology, and positive cytokeratin 19 expression Goblet cells were detected by positive MUC5AC staining | |||
| 3 | Bovine-derived conjunctiva | no |
Bovine-derived bulbar conjunctiva Isolation of conjunctival epithelial cells by homogenization of cells using dispase and Trypsin-EDTA Expansion of conjunctival cells at 5 × 105 cells/cm2 on collagen-coated transwell inserts in complete growth medium For 3D culture, cells were maintained at the air-liquid interface from day 5 onwards Mature conjunctival cells were detected by stratification, morphology, and cytokeratin 4 and 13 expression Goblet cells were not detected | [ |
| 4 | Rabbit-derived conjunctiva | yes |
New Zealand white rabbit-derived palpebral and fornical conjunctiva Isolation of conjunctival progenitor cells by homogenization of cells using dispase II and Trypsin-EDTA Expansion of conjunctival cells onto a collagen-coated cell culture dish in growth medium to sub-confluence For 3D culture, conjunctival cells were seeded at 1.1 × 106 cells/cm2 in a temperature-responsive culture dish, and after 4 days, a second cell layer was seeded at 1.1 × 106 cells/cm2 Mature conjunctival cells were detected by stratification, morphology, and cytokeratin 4 and 19 expression Goblet cells were detected by positive MUC5AC staining | [ |
| 5 | Human-derived conjunctiva | yes |
Human donor-derived biopsy specimens from superior temporal bulbar conjunctiva Isolation of conjunctival cells by homogenization using protease and differential attachment to plastic cell culture dishes Expansion of cells at 1.4 × 103 cells/cm2 on plastic culture dishes in bronchial epithelial growth medium (BEGM) For 3D culture, cells were seeded at 2.1 × 104 cells/cm2 onto transwell inserts in a mixed medium (BEGM/DMEM) and maintained at air-liquid interface from day 5 onwards Mature conjunctival cells were detected by stratification, morphology, and positive cytokeratin 19 staining Goblet cells were detected by positive MUC5AC staining | [ |
| 6 | Human-derived conjunctiva |
Human donor-derived conjunctiva from 6 different regions in initial experiments; the inferior fornical conjunctiva, as the best source of conjunctival stem cells, was then used in further 3D cell culture experiments Isolation of conjunctival cells by homogenization using Trypsin-EDTA | [ | |
| no |
Expansion on amniotic membrane at 1.7 × 104 cells/cm2 with/without feeder cells in control medium (K) or without feeder cells in XerumFree (XF) or keratinocyte (SFM) medium for up to 7 days Mature conjunctival cells were detected by stratification, morphology, and positive cytokeratin 13 and 19 staining when cultured in K or XF; cells in SFM failed to attach to the amniotic membrane Goblet cells were not detected | |||
| no-few |
Expansion on fibrin glue gel at 1.7 × 104 cells/cm2 with feeder cells in control medium (K) or without feeder cells in XerumFree medium (XF) for up to 7 days Mature conjunctival cells were detected by stratification, morphology, and positive cytokeratin 13 and 19 staining when cultured in K or XF Goblet cells were not detected by MUC5AC staining, but few MUCS5AC transcripts were detected by qPCR | |||
| 7 | Human-derived conjunctiva |
Human donor-derived bulbar conjunctiva Isolation of conjunctival cells (epithelial cells and fibroblasts) by explant culture on plastic dishes in epithelial cell culture medium Preparation of a fibrin scaffold with 1 × 105 fibroblasts/mL incorporated into the scaffold and 1 × 105 epithelial cells/cm2 seeded onto the scaffold surface 24h after polymerization | [ | |
| Few-no |
Cultures of the scaffolds submerged in epithelial cell culture medium Mature conjunctival cells were detected by stratification, morphology, and positive cytokeratin 19 staining Goblet cells were detected by lectin staining of glycoconjugates (HPA) and MUC5AC ELISA at day 7, but no goblet cells were detected at day 14 by lectin staining of glycoconjugates (HPA) | |||
|
Cultures of the scaffolds were maintained at the air-liquid interface from day 3 onwards in epithelial cell culture medium Mature conjunctival cells were detected by stratification, morphology, and positive cytokeratin 19 staining Goblet cells were detected by lectin staining of glycoconjugates (HPA) and MUC5AC ELISA at day 7 |
DMEM: Dulbecco’s modified eagle medium, EDTA: ethylenediaminetetraacetic acid, ELISA: enzyme-linked immunosorbent assay, HPA: Helix pomatia agglutinin, MUC5AC: mucin 5AC, qPCR: quantitative real time polymerase chain reaction.
Cell culture medium composition.
| Medium | Composition | Ref. | |
|---|---|---|---|
| 1 | CjSC Medium |
DMEM/F-12 (3:1) 10% fetal bovine serum 1% penicillin-streptomycin 1× insulin-transferrin-selenium 10 ng/mL epidermal growth factor 400 ng/mL hydrocortisone 0.1 nM cholera toxin 2 nM 3,3´,5-triiodo-L-thyronine 10 µM Y27632 1 µM A83-01 1 µM DMH1 | [ |
| Goblet cell differentiation medium |
Keratinocyte SFM 1% penicillin-streptomycin 50 µg/mL bovine pituitary extract 5 ng/mL epidermal growth factor 100 ng/mL bone morphogenetic protein 4 10 ng/mL fibroblast growth factor 10 100 ng/mL interleukin 13 1 µM A83-01 | ||
| 2 | CEC Medium |
DMEM/F-12 (1:1) 10% fetal bovine serum 1% penicillin-streptomycin 5 µg/mL transferrin 10 ng/mL epidermal growth factor 400 ng/mL hydrocortisone 0.1 nM cholera toxin 0.075% sodium bicarbonate 0.18 mM adenin 5 µg/mL insulin 2 nM 3,3´,5-triiodo-L-thyronine | [ |
| Differentiation medium |
DMEM/F-12 (1:1) 10% fetal bovine serum 1% penicillin-streptomycin 5 µg/mL transferrin 0.5 ng/mL epidermal growth factor 400 ng/mL hydrocortisone 0.1 nM cholera toxin 0.075% sodium bicarbonate 0.18 mM adenin 5 µg/mL insulin 2 nM 3,3´,5-triiodo-L-thyronine | ||
| 3 | Complete growth medium |
DMEM/F-12 (1:1) 10% fetal bovine serum 1% penicillin-streptomycin 2 mM L-glutamine 10 ng/mL epidermal growth factor 2 µg/mL hydrocortisone 0.1 µg/mL cholera toxin 50 µg/mL gentamycin 5 µg/mL insulin | [ |
| 4 | Growth medium |
DMEM/F-12 (1:1) 10% fetal bovine serum 1% penicillin-streptomycin 5 µg/mL insulin 5µg/mL transferrin 5 ng/mL selenium 10 ng/mL epidermal growth factor 10 ng/mL nerve growth factor | |
| 5 | Bronchial epithelial growth medium |
Bronchial epithelial growth medium (BEGM) 5 µg/mL insulin 500 ng/mL hydrocortisone 500 ng/mL epinephrine 6.5 ng/mL triiodo-thyronine 10 ng/mL transferrin 10 ng/mL retinoic acid 0.13 mg/mL bovine pituitary extract 50 µg/mL:50 ng/mL gentamycin:amphotericin 10 ng/mL epidermal growth factor 0.15 mg/mL bovine serum albumin | [ |
| Mixture Medium |
BEGM:DMEM (1:1) 5 µg/mL insulin 500 ng/mL hydrocortisone 500 ng/mL epinephrine 6.5 ng/mL triiodo-thyronine 10 ng/mL transferrin 10 ng/mL retinoic acid 0.13 mg/mL bovine pituitary extract 50 µg/mL:50 ng/mL gentamycin:amphotericin 0.5 ng/mL epidermal growth factor 0.15 mg/mL bovine serum albumin | ||
| 6 | Control medium (K) |
DMEM/F-12 (2:1) 10% fetal bovine serum 50 µg/mL penicillin-streptomycin 4 mM glutamine 5 µg/mL insulin 0.4 µg/mL hydrocortisone 0.18 mM adenine 8.1 µg/mL cholera toxin 2 mM triiodo-thyronine 10 ng/mL epidermal growth factor | [ |
| XerumFree medium (XF) |
DMEM/F-12 (2:1) 10% XerumFree XF205 50 µg/mL penicillin-streptomycin 4 mM glutamine 5 µg/mL insulin 0.4 µg/mL hydrocortisone 0.18 mM adenine 8.1 µg/mL cholera toxin 2 mM triiodo-thyronine 10 ng/mL epidermal growth factor | ||
| Keratinocyte serum Free medium (SFM) |
Keratinocyte SFM 50 µg/mL bovine pituitary extract 5 ng/mL epidermal growth factor | ||
| 7 | Epithelial cell culture medium |
DMEM/F-12 10% human serum 25 µg/mL fungizone 5000 U penicillin-streptomycin 1 µg/mL insulin 0.5 µg/mL hydrocortisone 2 ng/mL epidermal growth factor | [ |
Figure 4Entry and exit pathway of measles virus and entry pathway of adenovirus type 37. (a) Schematic representation of the entry and exit process of wild-type measles virus (MeV) in epithelia. MeV is transmitted to epithelial cells via the receptor nectin-4 located at the basolateral membrane. Entry occurs via membrane fusion. Progeny MeV particles bud from the apical surface of epithelial cells into the lumen [152,153]. This panel (a) was adapted from [111]. (b) Schematic representation of the entry pathway of adenovirus 37 (Ad37). Ad37 enters epithelial cells by binding the ganglioside (GD1a) receptor and α/β integrins as co-receptors. Cell entry occurs by clathrin-mediated endocytosis [141,154]. This panel (b) was adapted from [135]. Abbreviations: Ad, adenovirus; MeV, wild-type, i.e., pathogenic measles virus; GD1a, ganglioside. This figure was created with Adobe Inc. (2021) Adobe illustrator. Retrieved from https://adobe.com/products/illustrator, Dublin, Ireland, software purchased on 6 April 2021, link accessed last 6 April 2021, software last accessed on 12 October 2021).
Figure 5The influence of distinct triggers on the airway epithelium. Several triggers can affect or harm the epithelium, which consequently lead to a complex signaling cascade including the activation of T helper 2 (Th2) cells and the release of Th2 cytokines. Following cytokine secretion, several types of immune cells e.g., B cells (BC), eosinophil granulocytes (EoG), basophil granulocytes (BG), or mast cells (MC) are activated. In addition, through the direct stimulation of innate lymphoid cells type 2 (ILC-2), interleukin (IL)-4, IL-5, and/or IL-13 are also released. Clinically, through the activation of these cellular actors, mucus production, airway inflammation, and bronchoconstriction are observed in the bronchi. In addition, chronic inflammation in the nasal cavity leads to the development of nasal polyps. This figure was adapted from [175,176,186,187,188] and was created with BioRender.com. (left) Nasal polyps of a patient with a chronic rhinosinusitis and nasal polyps (CRSwNP). In this figure, polyps of the nasal mucosa are depicted from a patient with a chronic rhinosinusitis and allergy, who suffered from recurrent rhinitis and impediment of nasal breathing.